gabapentin has been researched along with Neonatal Abstinence Syndrome in 8 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Neonatal Abstinence Syndrome: Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The general population model included age, hepatitis C virus infection, days of opioid used by type, number of cigarettes used daily, and the following medications used in the last 30 day of pregnancy: bupropion, antinausea medicines, benzodiazepines, antipsychotics, and gabapentin." | 4.02 | Development and Validation of a Model to Predict Neonatal Abstinence Syndrome. ( Cooper, WO; Dudley, J; Harrell, FE; Hartmann, K; Martin, PR; Patrick, SW; Slaughter, JC; Stratton, S, 2021) |
| " When medically indicated, limiting use of multiple psychiatric medications, particularly benzodiazepines and gabapentin, during pregnancy should be considered to improve NAS outcomes." | 3.88 | Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity. ( Nikita, FNU; Saia, K; Schiff, DM; Shaw, D; Shrestha, H; Thomas, Z; Thomas-Lewis, JA; Wachman, EM; Warden, AH, 2018) |
| "Gabapentin use has also been recommended for hyperemesis gravidarum and restless leg syndrome in pregnant mothers." | 1.42 | Neonatal Gabapentin Withdrawal Syndrome. ( Bearer, CF; Carrasco, M; Rao, SC; Sundararajan, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loudin, S | 2 |
| Haas, J | 2 |
| Payne, M | 1 |
| Linz, MF | 1 |
| Meaney-Delman, D | 1 |
| Honein, MA | 1 |
| Saunders, A | 1 |
| Maddox, TR | 1 |
| Andrews, L | 1 |
| Miller, B | 1 |
| Davies, TH | 1 |
| Patrick, SW | 1 |
| Slaughter, JC | 1 |
| Harrell, FE | 1 |
| Martin, PR | 1 |
| Hartmann, K | 1 |
| Dudley, J | 1 |
| Stratton, S | 1 |
| Cooper, WO | 1 |
| Wachman, EM | 1 |
| Warden, AH | 1 |
| Thomas, Z | 1 |
| Thomas-Lewis, JA | 1 |
| Shrestha, H | 1 |
| Nikita, FNU | 1 |
| Shaw, D | 1 |
| Saia, K | 1 |
| Schiff, DM | 1 |
| Abdi, HH | 1 |
| Maitre, NL | 1 |
| Benninger, KL | 1 |
| Hester, ME | 1 |
| Slaughter, JL | 1 |
| Carrasco, M | 1 |
| Rao, SC | 1 |
| Bearer, CF | 1 |
| Sundararajan, S | 1 |
| Murray, S | 1 |
| Prunty, L | 1 |
| Davies, T | 1 |
| Evans, J | 1 |
| Werthammer, J | 1 |
| Carter, BS | 1 |
| Brunkhorst, J | 1 |
1 review available for gabapentin and Neonatal Abstinence Syndrome
| Article | Year |
|---|---|
Neonatal pain management.
Topics: Amines; Analgesics, Opioid; Anti-Anxiety Agents; Barbiturates; Chronic Pain; Cyclohexanecarboxylic A | 2017 |
7 other studies available for gabapentin and Neonatal Abstinence Syndrome
| Article | Year |
|---|---|
Identifying Co-Exposure to Opiates and Gabapentin During Pregnancy.
Topics: Analgesics, Opioid; Excitatory Amino Acid Antagonists; Female; Follow-Up Studies; Gabapentin; Humans | 2020 |
Abnormal Presentation of Hypoxic Ischemic Encephalopathy Attributed to Polysubstance Exposure.
Topics: Benzodiazepines; Buprenorphine; Female; Gabapentin; Heroin; Humans; Hypoxia-Ischemia, Brain; Infant, | 2019 |
Development and Validation of a Model to Predict Neonatal Abstinence Syndrome.
Topics: Adult; Analgesics; Antiemetics; Antipsychotic Agents; Benzodiazepines; Bupropion; Female; Gabapentin | 2021 |
Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Topics: Adult; Analgesics, Opioid; Benzodiazepines; Buprenorphine; Female; Gabapentin; Humans; Infant; Infan | 2018 |
Gabapentin Use for Hospitalized Neonates.
Topics: Analgesics, Non-Narcotic; Anticonvulsants; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Chromoso | 2019 |
Neonatal Gabapentin Withdrawal Syndrome.
Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans | 2015 |
An Atypical Withdrawal Syndrome in Neonates Prenatally Exposed to Gabapentin and Opioids.
Topics: Amines; Analgesics, Opioid; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid | 2017 |